Saturday, June 4, 2016

Opdivo (nivolumab) and Yervoy (ipilimumab) Combination Regimen Shows Clinically Meaningful Responses in First-Line Advanced Non-Small Cell Lung Cancer, In Updated Phase 1b Study CheckMate -012

… with chemotherapy-naïve advanced non-small cell lung cancer (NSCLC), as either a monotherapy … /4 AEs per category.
About Lung Cancer
Lung cancer is the leading cause of … melanoma; CheckMate057 – non-squamous non-small cell lung cancer (NSCLC); CheckMate 025 - renal …

No comments:

Post a Comment